We see
a bright
future

for Canada's life
science industry.

We are
building
on solid
ground

With a wealth of globally-competitive scientific discovery, Canada is primed to lead the life sciences world. To make this a reality, at adMare BioInnovations, we use our scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, robust ecosystems and industry-ready talent — and re-invest our returns back into the Canadian industry to ensure it is sustained for the long-term.

Building

Companies

Companies

Building

Ecosystems

ecosystems

Building

Talent

talent

Working together

with our partners in government, academia, industry and the investment community, if we focus on these three things: building companies, building ecosystems, and building talent, we will realize our vision of Canadian life sciences leading the world.

Gordon C. McCauley

President & CEO,
adMare BioInnovations

What’s
new in our
community

See all news

September 26 2022

Yes, Canada performed well throughout the pandemic, but at what cost?

Op-ed published in La Presse coauthered by Gordon C. McCauley, President & CEO of adMare BioInnovations, and his colleague Lesia Babiak, Head of Canada Government Affairs & Policy at Johnson & Johnson

September 20 2022

adMare Appoints Patricia Gauthier to the Board of Directors

adMare BioInnovations welcomes Patricia Gauthier, President and General Manager of Moderna Canada, as the newest member of its Board of Directors. Patricia brings to adMare a wealth of leadership experience in global pharma and biotech.

September 19 2022

Zucara Therapeutics’ Positive Proof-of-Concept Data Secures Continued Funding Ahead of Planned Phase 2 Clinical Trial of ZT-01

Zucara Therapeutics Inc., a diabetes life sciences company developing the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people with diabetes, today announced that its positive proof-of-concept data has enabled the Company to secure continued funding for a Phase 2 clinical study of ZT-01, which is expected to begin in Q1 2023.

Events you
can't miss

See all events

thumbnail

adMare Global Leaders Series

Oct 14, 2022


Investing in Innovation for the Canadian Life Sciences Sector

Shape the future of Canada’s life science industry with us

adMare offers a tremendous opportunity to advance your career while making a significant contribution to our mission of building companies, ecosystems, and talent.

Discover the team adMare experience

Join a Community with reach

Looking to connect to Canada’s life sciences industry builders? The adMare Community is a vibrant digital ecosystem that brings together over 1,300 life science professionals, from students to CEOs, from Victoria to Charlottetown. Everyone is welcome to join, engage, explore, share, and contribute to Canadian life science leading the world.

Join Us